Shots:Chimerix has submitted the NDA of dordaviprone (small molecule imipridone targeting the mitochondrial protease ClpP & dopamine receptor D2) to the US FDA, seeking accelerated approval for treating recurrent H3 K27M-mutant diffuse glioma
Chimerix has also requested priority review along with a Rare Paediatric Disease PRV as a part of submission, as the…
